Finizio Robert G

Average Profitability
<0.0001%
Insider Buys Quantity
5
Insider Buys Sum
$549,978.80
Insider Sells Quantity
24
Insider Sells Sum
$22.15M

Insider Activity of Finizio Robert G

The largest purchase of all time was on 2019-10-25 and amounted to 72000 shares of TherapeuticsMD, Inc. for $198,000.

The largest sale of all time was on 2014-03-26 and amounted to 1964106 shares of TherapeuticsMD, Inc. for $13.15M.

Biography of Finizio Robert G

No biography is available at this moment.

2021-05-11SaleTherapeuticsMD, Inc.
TXMD
CEO
67,697
0.0003%
$1.04$70,405-33.65%
2020-06-09PurchaseTherapeuticsMD, Inc.
TXMD
CEO
46,000
0.0003%
$1.44$66,360-2.84%
2020-06-05PurchaseTherapeuticsMD, Inc.
TXMD
CEO
30,000
0.0002%
$1.15$34,600+16.1%
2019-10-25PurchaseTherapeuticsMD, Inc.
TXMD
CEO
72,000
0.0283%
$2.75$198,000-43.31%
2019-08-20PurchaseTherapeuticsMD, Inc.
TXMD
CEO
35,000
0.0003%
$2.74$95,900-21.53%
2019-08-09PurchaseTherapeuticsMD, Inc.
TXMD
CEO
52,405
0.0004%
$2.96$155,119-25.48%
2018-12-20SaleTherapeuticsMD, Inc.
TXMD
CEO
92,910
0.0008%
$3.63$336,892-4.92%
2018-12-19SaleTherapeuticsMD, Inc.
TXMD
CEO
92,000
0.0008%
$3.70$340,216-10.31%
2018-12-07SaleTherapeuticsMD, Inc.
TXMD
CEO
92,000
0.0008%
$4.60$423,568-20.31%
2018-12-06SaleTherapeuticsMD, Inc.
TXMD
CEO
92,000
0.0008%
$4.57$420,624-22.03%
2018-11-27SaleTherapeuticsMD, Inc.
TXMD
CEO
92,000
0.0008%
$4.80$442,060-24.23%
2018-11-26SaleTherapeuticsMD, Inc.
TXMD
CEO
92,000
0.0008%
$4.86$447,028-24.28%
2018-11-13SaleTherapeuticsMD, Inc.
TXMD
CEO
184,000
0.0008%
$2.46$451,794-21.43%
2018-11-12SaleTherapeuticsMD, Inc.
TXMD
CEO
184,000
0.0008%
$2.42$444,526-20.17%
2018-10-26SaleTherapeuticsMD, Inc.
TXMD
CEO
184,000
0.0008%
$2.61$480,130-24.16%
2018-10-25SaleTherapeuticsMD, Inc.
TXMD
CEO
184,000
0.0008%
$2.78$510,674-29.69%
2018-10-12SaleTherapeuticsMD, Inc.
TXMD
CEO
184,000
0.0008%
$2.77$510,582-23.99%
2018-10-11SaleTherapeuticsMD, Inc.
TXMD
CEO
184,000
0.0008%
$2.87$528,982-26.12%
2018-09-21SaleTherapeuticsMD, Inc.
TXMD
CEO
184,000
0.0008%
$3.39$623,006-34.14%
2018-09-20SaleTherapeuticsMD, Inc.
TXMD
CEO
184,000
0.0008%
$3.34$614,726-35.41%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.